Back
Candel Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
CADL
Candel Therapeutics
Last Price:
$8.82
Seasonality Move:
-11.47%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.
Candel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.77 | Buy |
| 20-day SMA: | 6.36 | Buy |
| 50-day SMA: | 5.59 | Buy |
| 200-day SMA: | 6.17 | Buy |
| 8-day EMA: | 8.03 | Buy |
| 20-day EMA: | 6.87 | Buy |
| 50-day EMA: | 6.1 | Buy |
| 200-day EMA: | 5.48 | Buy |
Candel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 61.29 | Buy |
| Chaikin Money Flow: | -45199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Candel Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Candel Therapeutics Stock
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 8.80 while CADL 8-day simple moving average is 7.77, which is a Buy signal.
-
The stock price of CADL is 8.80 while Candel Therapeutics 20-day SMA is 6.36, which makes it a Buy.
-
Candel Therapeutics 50-day simple moving average is 5.59 while CADL share price is 8.80, making it a Buy technically.
-
CADL stock price is 8.80 and Candel Therapeutics 200-day simple moving average is 6.17, creating a Buy signal.
CADL Technical Analysis vs Fundamental Analysis
Buy
61
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy or a Sell?
-
Candel Therapeutics stock is rated a BuyThe current Candel Therapeutics [CADL] share price is $8.80. The Score for CADL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Candel Therapeutics Stock Info
Market Cap:
285.8M
Price in USD:
8.80
Share Volume:
1.1M
Candel Therapeutics 52-Week Range
52-Week High:
14.60
52-Week Low:
1.10
Buy
61
Candel Therapeutics (CADL)
is a Buy
Candel Therapeutics Share Price Forecast
-
What is the Candel Therapeutics stock price today?The Candel Therapeutics stock price is 8.80 USD today.
-
Will CADL stock go up or go down?Candel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Candel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Candel Therapeutics is not overvalued.
Is Candel Therapeutics Stock a Buy?
-
Candel Therapeutics share price is 8.80 while CADL 8-day exponential moving average is 8.03, which is a Buy signal.
-
The stock price of CADL is 8.80 while Candel Therapeutics 20-day EMA is 6.87, which makes it a Buy.
-
Candel Therapeutics 50-day exponential moving average is 6.10 while CADL share price is 8.80, making it a Buy technically.
-
CADL stock price is 8.80 and Candel Therapeutics 200-day simple moving average is 5.48, creating a Buy signal.
Fundamental Analysis of Candel Therapeutics
Is Candel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.03 per share.
Technical Analysis of Candel Therapeutics
Should I short Candel Therapeutics stock?
-
CADL Moving Average Covergence Divergence (MACD) indicator is 0.98, suggesting Candel Therapeutics is a Buy
-
Candel Therapeutics Relative Strength Index (RSI) is 61.29, which suggest Candel Therapeutics is overbought
-
The Bollinger Bands (25) for Candel Therapeutics is ( - ), which suggest Candel Therapeutics is a Buy
-
The Bollinger Bands (100) for Candel Therapeutics is ( - ), which suggest Candel Therapeutics is a Buy
* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.